To understand the significance of Ondamex, one must first examine its components individually. Ondansetron, the first component, belongs to a class of drugs known as 5-HT3 receptor antagonists. It works by blocking the actions of serotonin, a chemical in the body that can trigger nausea and vomiting. This mechanism revolutionized oncology in the 1990s, transforming chemotherapy from an ordeal defined by uncontrollable sickness into a more manageable process. The second component, Dexamethasone, is a long-acting corticosteroid. Its primary function is to mimic the effects of cortisol, a hormone produced by the adrenal glands, to suppress inflammation and modulate the immune system. When these two drugs are combined, they address the physiological triggers of distress from two different angles, creating a "dual shield" against symptoms.